المؤلفون: Verkouteren, B.J.A., Cosgun, B., Reinders, M.G.H.C., Kessler, P.A.W.K., Vermeulen, R.J., Klaassens, M., Lambrechts, S., van Rheenen, J.R., van Geel, M., Vreeburg, M., Mosterd, K.

المصدر: British Journal of Dermatology ; volume 186, issue 2, page 215-226 ; ISSN 0007-0963 1365-2133

الاتاحة: http://dx.doi.org/10.1111/bjd.20700
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.20700
https://onlinelibrary.wiley.com/doi/full-xml/10.1111/bjd.20700

المؤلفون: Verkouteren, B.J.A., Verkouteren, B.J.A., Cosgun, B., Reinders, M.G.H.C., Kessler, P.A.W.K., Vermeulen, R.J., Klaassens, M., Lambrechts, S., van Rheenen, J.R., van Geel, M., Vreeburg, M., Mosterd, K.

المصدر: British Journal of Dermatology vol.186 (2022) nr.2 p.215-226 [ISSN 0007-0963]

مصطلحات الفهرس: QUALITY-OF-LIFE, CARCINOMA SYNDROME, DOUBLE-BLIND, OCULAR MANIFESTATIONS, GERMLINE MUTATIONS, HEDGEHOG PATHWAY, TUMOR, SUFU, RISK, MEDULLOBLASTOMA, Article

URL: https://cris.maastrichtuniversity.nl/en/publications/bd537b77-d1cc-42fa-8ce7-f62f50fb889a
https://cris.maastrichtuniversity.nl/ws/files/76967162/Verkouteren_2021_A_guideline_for_the_clinical.pdf
https://cris.maastrichtuniversity.nl/ws/files/76967162/Verkouteren_2021_A_guideline_for_the_clinical.pdf